Dennis Hom
Geen lopende functies
Vermogen: - $ op 31-05-2024
Loopbaan van Dennis Hom
Eerdere bekende functies van Dennis Hom
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SAGIMET BIOSCIENCES INC. | Financieel Directeur/CFO | 01-10-2017 | 01-08-2023 |
| ACHAOGEN | Financieel Directeur/CFO | 01-01-2013 | 31-03-2014 |
| Investor Relations Contact | 01-01-2013 | 31-03-2014 | |
| Public Communications Contact | 01-01-2013 | 31-03-2014 | |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2011 | 01-01-2012 |
Opleiding van Dennis Hom
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Director of Finance/CFO | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectoraal
| Health Technology | 4 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Dennis Hom
- Ervaring
